- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02152501
Exercise and Weight Control
July 18, 2019 updated by: James Roemmich, USDA Grand Forks Human Nutrition Research Center
Exercise and Weight Control: A Search for Biological and Neurobehavioral Compensatory Mechanisms That Defend Against Exercise-Induced Negative Energy Balance
The purpose of this study is to research the effects of exercise on calories eaten and expended.
The investigator expects to find out whether subjects change their eating and activity behaviors when starting an exercise program.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Dakota
-
Grand Forks, North Dakota, United States, 58203
- USDA Grand Forks Human Nutrition Reserach Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 to 40 years old
- BMI of 25.0 - 35 kg/m2
- willing to consent to study conditions
- not taking medications that affects energy expenditure or eating
- not using tobacco or nicotine products
- no food allergies or limitations to eating certain food that would prohibit them from eating the study foods
- not be dieting to lose weight
- no major health problems
- cannot have known cardiovascular, pulmonary or metabolic disease
- cannot be regularly exercising in an aerobic manner more than twice per week
- must have a liking of at least 5 out of 10 for 75% of the study foods
Exclusion Criteria:
- < 18 or > 40 years old
- BMI < 25 or >35 kg/m2
- currently pregnant or trying to become pregnant, or lactating
- currently using tobacco or nicotine
- taking medication that affects energy expenditure or eating
- food allergies to foods used in the study
- regularly exercising in an aerobic manner more than twice per week
- major health problems
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Exercise Energy Expenditure 300 kcal/day
Subjects will be randomly assigned to this group and will exercise energy expenditure of 300 kcal/day.
|
|
Experimental: Exercise Energy Expenditure 600 kcal/day
Subjects will be randomly assigned to this group and will exercise energy expenditure of 600 kcal/day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Negative Energy Balance as assessed by changes in adipose tissue
Time Frame: End Training (weeks 10-12)
|
Whether participants were able to maintain a negative energy balance will be assessed by pre-post changes in stored adipose tissue, as assessed by a dual-energy x-ray absorptiometry scan (DEXA).
|
End Training (weeks 10-12)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in relative reinforcing value (RRV) of food
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
|
RRV of food will be assessed by evaluating the number of responses (mouse button presses) a participant is willing to complete to gain access to food or an alternative sedentary activity.
|
Pre-intervention (week 0) and End Training (weeks 10-12)
|
Average daily calories consumed as assessed by dietary recall
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
|
On two weekdays and one weekend day, participants will fill out the Automated Self-Administered 24-Hour Dietary Recall (ASA24) to estimate dietary intake (total energy, grams carbohydrates, fat, protein, alcohol).
|
Pre-intervention (week 0) and End Training (weeks 10-12)
|
Pre-post intervention changes in Ghrelin plasma levels
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
|
Participants will provide a fasting blood sample collected in ethylenediaminetetraacetic acid (EDTA)-coated and serum tubes.
Changes in acylated Ghrelin will be measured via enzyme-linked immunosorbent assay (ELISA).
|
Pre-intervention (week 0) and End Training (weeks 10-12)
|
Pre-post intervention changes in glucagon-like peptide 1 (GLP-1) plasma levels
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
|
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes.
Changes in GLP-1 concentrations will be measured via ELISA.
|
Pre-intervention (week 0) and End Training (weeks 10-12)
|
Pre-post intervention changes in Ghrelin concentrations
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
|
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes.
Changes in Ghrelin concentrations will be measured via ELISA.
|
Pre-intervention (week 0) and End Training (weeks 10-12)
|
Pre-post intervention changes in irisin concentrations
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
|
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes.
Changes in irisin concentrations will be measured via ELISA.
|
Pre-intervention (week 0) and End Training (weeks 10-12)
|
Pre-post intervention changes in myostatin plasma levels
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
|
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes.
Changes in myostatin levels will be measured via ELISA.
|
Pre-intervention (week 0) and End Training (weeks 10-12)
|
Change in relative reinforcing value (RRV) of physical activity
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
|
RRV of physical activity will be assessed by evaluating the number of responses (mouse button presses) a subject is willing to complete to gain access to physical activity or a sedentary alternative.
|
Pre-intervention (week 0) and End Training (weeks 10-12)
|
Change in minutes of sedentary behavior, as assessed by activity tracker
Time Frame: Pre-intervention (week 0) and End Training (weeks 10-12)
|
Minutes of sedentary behavior (non-exercise activity) will be assessed by having participants wear an Actigraph accelerometer for 7 days (minimum 10 hours per day) on the right hip.
|
Pre-intervention (week 0) and End Training (weeks 10-12)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: James Roemmich, PhD, USDA GFHNRC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2016
Primary Completion (Actual)
November 1, 2016
Study Completion (Actual)
January 1, 2017
Study Registration Dates
First Submitted
May 22, 2014
First Submitted That Met QC Criteria
May 28, 2014
First Posted (Estimate)
June 2, 2014
Study Record Updates
Last Update Posted (Actual)
July 23, 2019
Last Update Submitted That Met QC Criteria
July 18, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GFHNRC028
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Children's Hospital Los AngelesUniversity of Southern California; Tufts Medical CenterRecruitingOverweight and Obesity | Overweight AdolescentsUnited States
-
University of AarhusThe Danish Dairy Research Foundation, Denmark; Sygekassernes HelsefondCompletedOverweight and Obesity | Overweight Adolescents | Metabolic DiseaseDenmark
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
University Hospital Bispebjerg and FrederiksbergUniversity of CopenhagenCompleted
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Khyber Medical University PeshawarRecruitingObesity, OverweightPakistan
-
National Taiwan University HospitalCompleted
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.RecruitingBody Weight | Overweight and ObesityCroatia
Clinical Trials on Exercise Energy Expenditure 300 kcal/day
-
Purdue UniversityAlmond Board of CaliforniaCompleted
-
USDA Grand Forks Human Nutrition Research CenterCompleted
-
North Dakota State UniversityTerminatedWeight Loss | Overweight and ObesityUnited States
-
University of KansasNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of Alabama at BirminghamNot yet recruitingCardiovascular Diseases | Obesity | Insulin Sensitivity/Resistance | Metabolic Disease | Energy Expenditure | MetabolismUnited States
-
Nanyang Technological UniversityMinistry of Education, SingaporeCompletedOverweight and ObesitySingapore
-
Aarhus University HospitalUnknown
-
NestléCompleted
-
University of Kansas Medical CenterCompletedObesity | Sarcopenia | Compensated CirrhosisUnited States